|
시장보고서
상품코드
2058615
CRISPR 기반 게놈 편집 시장 : 제품·서비스별, 용도별, 최종 용도별, 국가별, 지역별 - 세계 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)CRISPR-based Gene Editing Market, By Product & Service, By Application, By End Use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
CRISPR 기반 게놈 편집 시장 규모는 2025년에 46억 520만 달러로 평가되며, 2026-2033년에 CAGR 15.1%로 확대할 것으로 전망되고 있습니다.
CRISPR 기반 유전체 편집이란 생물체 내에서 DNA 서열을 정밀하게 변형하기 위해 사용되는 일련의 첨단 생명공학 기술을 의미합니다. 이를 통해 연구자는 특정 위치에서 유전 물질을 추가, 제거 또는 변형할 수 있게 되어, 유전공학의 정확성과 효율성이 향상됩니다. CRISPR 기반 유전체 편집 시장은 분자생물학 및 생명공학 분야의 큰 진보를 나타내며, 매우 정밀하고 효율적인 유전체 변형을 가능하게 합니다. 예를 들어 2025년 NIH.gov가 발표한 분자생물학의 발전에 관한 조사에서는 현대 분자생물학이 단일 세포 수준의 생물학적 시스템 분석으로 확대되어, 실험마다 수천 개에서 수백만 개에 이르는 개별 세포에 걸친 유전자 발현의 변동을 감지할 수 있게 되었다는 점이 강조되고 있습니다. 이는 조직 전체에서 신호를 평균화하던 기존의 벌크 레벨 방식과 비교한 것입니다. 이러한 높은 정확도는 혁신을 가속화하고, 치료 분야에서의 CRISPR 활용을 확대할 것으로 기대됩니다.
CRISPR 기반 유전체 편집 시장 - 시장 역학
유전성 질환 유병률 증가가 시장 수요를 견인하고 있습니다.
유전성 질환의 증가는 게놈 시퀀싱 및 임상 유전체학의 발전에 힘입어, 희귀하고 지금까지 진단되지 않았던 신경발달장애에 대한 연구가 활발해지는 데 기여하고 있습니다. RPS6KC1 등의 유전자에서 새롭게 확인된 변이를 포함한 최근 발견들은 복잡한 신경질환 및 발달 장애에 대한 이해를 심화시키고 있습니다. 이러한 발전은 조기 진단 능력을 강화하고, 희귀 유전 질환에 대한 표적 치료제 개발을 가속화하고 있습니다.
전 세계에서 유전성 질환의 유병률이 증가하고 있는 것은 CRISPR 기반 유전체 편집에 대한 수요를 이끌고 있습니다. 이는 질병의 원인이 되는 변이를 정확하게 교정할 수 있게 하여, 표적화된 차세대 유전자 치료법의 개발을 지원하기 때문입니다. 예를 들어 2026년 미국 질병통제예방센터(CDC)의 보고서, 유전체학 및 건강 현황에 대한 연구 결과에 따르면 유전성 질환은 단일 유전자 변이에서 염색체 이상, 나아가 여러 유전자와 환경 요인의 복잡한 상호작용에 이르기까지 DNA의 변화에 기인한다는 점이 강조되고 있습니다. CDC 보고서에 따르면 희귀 질환 및 유전성 질환에는 다운증후군(신생아 약 700명 중 1명)과 같은 단일 유전자 질환이나 염색체 이상, 그리고 미국에서 약 3만 5,000명이 앓고 있는 낭포성 섬유증 등의 질환이 포함됩니다. 따라서 정확하고 개인 맞춤형이며, 완치의 가능성을 지닌 유전성 질환 치료법을 위한 CRISPR의 도입이 가속화되고 있습니다.
CRISPR 기반 유전체 편집 시장 ? 시장 세분화 분석:
전 세계 CRISPR 기반 유전체 편집 시장은 제품 및 서비스, 용도, 최종 용도, 그리고 지역별로 세분화되어 있습니다.
제품 및 서비스의 관점에서 볼 때, CRISPR 키트 및 시약은 게놈 편집 워크플로우에서 광범위하게 활용되고, 연구 분야에서 높은 채택률을 보이며, 유전자 변형에 있으며, 필수적인 역할을 수행함으로써 CRISPR 기반 게놈 편집 시장에서 큰 점유율을 차지하고 있습니다. 예를 들어 인도 정부 의약품국의 조사에 따르면 키트 및 시약에 대한 수요 증가가 인도 의료기기 산업의 확장에 크게 기여하고 있다는 점이 강조되고 있습니다. 이 보고서에 따르면 진단 검사 수요 증가로 인해 인도의 IVD 시약 수입 의존도는 약 65.4% 증가하여 약 8억 7,200만 달러에 달했습니다. 또한 의료기기 수입액은 약 85억 달러에 달했으며, 헬스케어 검진 및 검사 인프라의 확장에 따라 36.8% 증가했습니다. 이처럼 진단 및 연구 용도의 확대가 CRISPR 키트 및 시약에 대한 전 세계적인 수요를 촉진하고 있습니다.
용도별로 보면 CRISPR 기반 유전체 편집 시장에서 바이오메디컬 분야가 주요 영역을 차지하고 있습니다. 이는 치료법 개발, 유전성 질환 치료, 종양학 연구, 질병 진단 분야에서의 활용 확대, 그리고 ex vivo 및 in vivo 유전자 편집 기술의 도입 확대에 힘입은 결과입니다. 예를 들어 2025년 OECD 조사에 따르면 일본에서는 생의학 기술 및 첨단 헬스케어 기술의 활용이 증가하고 있는 것으로 나타났습니다. 일본은 GDP의 약 10.6%를 의료 분야에 지출하고 있으며, 1인당 의료비는 5,790달러에 육박하고, 국민 100%가 의료보험의 적용을 받고 있습니다. 또한 해당 국가에는 인구 100만 명당 약 184대의 CT, MRI, PET 스캐너가 도입되어 있으며, 인구 10만 명당 약 203명의 약사가 재직하고 있는 것으로 보아, 첨단 의료 기술의 도입이 활발히 이루어지고 있음을 알 수 있습니다. 이러한 헬스케어 인프라 확충은 CRISPR 기반 유전체 편집 시장에서 생의학 기술의 도입을 가속화하고 있습니다.
CRISPR 기반 유전체 편집 시장 - 지역별 분석
북미는 주요 생명공학 기업 및 제약 기업의 존재와 지속적인 연구개발 투자를 바탕으로, CRISPR 기반 유전체 편집 시장에서 중요한 위치를 차지하고 있습니다. 2025년 4월, 다나허 코퍼레이션은 Integrated DNA Technologies(IDT) 및 Aldevron을 통해 연구개발 생태계를 강화하고, CRISPR 기반 유전체 편집 역량을 향상시켰습니다. 이 회사는 고품질의 DNA, RNA 및 CRISPR 툴의 생산에 주력하여 차세대 유전자 편집 치료법 개발을 가속화하고, 맞춤형 치료 솔루션의 확장성을 높이는 것을 목표로 하고 있습니다. 이를 통해 CRISPR 혁신 및 치료법 개발 분야에서 북미의 주도적 위상이 더욱 공고해질 것입니다.
또한 아시아태평양에서는 생명공학 및 제약 산업의 확장에 힘입어 CRISPR 기반 유전체 편집 시장이 급속한 성장을 이룰 것으로 예상됩니다. 중국, 일본, 한국, 인도 등의 국가들은 정부의 지원책과 진보적인 정책 개혁에 힘입어 게놈 연구, 임상 시험 및 CRISPR 기반 제품 개발에 막대한 투자를 하고 있습니다. 2025년 5월, 뉴델리의 NASC 단지 내에 위치한 바라트 라트나 C. 수브라마니암 강당에서, PIB(언론정보국)이 발표한 바와 같이, 시브라지 싱 초한 연방 농업·농민복지부 장관이 인도 최초의 유전자 편집 쌀 품종인 'DRR Rice 100(캄라)' 및 'Pusa DST Rice 1'을 발표했습니다. ICAR가 CRISPR를 활용한 유전체 편집 기술로 개발한 이 품종들은 수확량 증가, 기후 적응성 향상, 그리고 물 절약 효과를 가져옵니다. 이번 발표로 인도는 유전자 편집 쌀 품종을 개발한 세계 최초의 국가가 되었습니다. 따라서 아시아태평양은 강력한 혁신과 정책 지원을 통해 CRISPR 도입을 주도하고 있습니다.
중국은 유전성 질환에 대해 CRISPR-Cas9을 활용한 인간 임상 시험을 실시한 최초의 국가로서, CRISPR 기반 유전체 편집 시장에서 중요한 역할을 하고 있습니다. 예를 들어 미국 국립보건원(NIH)은 중국의 현대적인 임상시험 시스템이 초기 대조군 인간 임상시험에 대한 최소한의 참여에서 시작해 대규모 다기관 무작위 임상연구 생태계로 급속히 확장되었음을 강조하고 있습니다. 체계적인 임상 연구 단계에 이르기까지 중국은 종양학, 순환기 질환, 감염증, 전통의학을 포함한 주요 치료 분야에서 수백 건의 다기관 공동 무작위 대조 시험(RCT)을 수행했습니다. 현대 임상시험에서는 2상/3상 시험 단계에서 수백 명에서 3,000명이 넘는 참가자가 참여하고 있으며, 이는 지난 수십 년간 100명 미만이었던 것에 비해 크게 증가한 수치입니다. 이처럼 중국의 임상 연구 확대는 CRISPR 유전자 편집 기술의 발전을 가속화하고 있습니다.
목차
제1장 CRISPR 기반 게놈 편집 시장 개요
제2장 개요
제3장 CRISPR 기반 게놈 편집 주요 시장 동향
제4장 CRISPR 기반 게놈 편집 산업 분석
제5장 CRISPR 기반 게놈 편집 시장 : 높아지는 지정학적 긴장의 영향
제6장 CRISPR 기반 게놈 편집 시장 구도
제7장 CRISPR 기반 게놈 편집 시장 : 제품·서비스별
제8장 CRISPR 기반 게놈 편집 시장 : 용도별
제9장 CRISPR 기반 게놈 편집 시장 : 최종 사용별
제10장 CRISPR 기반 게놈 편집 시장 : 지역별
제11장 주요 벤더 분석 : CRISPR 기반 게놈 편집 산업
제12장 AnalystView의 전방위 전망
KSA 26.06.23CRISPR-based Gene Editing Market size was valued at US$ 4,605.2 Million in 2025, expanding at a CAGR of 15.1% from 2026 to 2033.
CRISPR-based gene editing refers to a set of advanced biotechnology tools used to precisely modify DNA sequences within living organisms. It enables researchers to add, remove, or alter genetic material at specific locations, improving accuracy and efficiency in genetic engineering. The CRISPR-based Gene Editing market represents a major advancement in molecular biology and biotechnology, enabling highly precise and efficient genome modification. For instance, in 2025, research on advancements in molecular biology by NIH.gov highlights that modern molecular biology has expanded to analyze biological systems at single-cell resolution, enabling detection of gene expression variability across thousands to millions of individual cells per experiment, compared to earlier bulk-level methods that averaged signals across entire tissues. This precision is expected to accelerate innovation and expand CRISPR adoption in therapeutics.
CRISPR-based Gene Editing Market- Market Dynamics
Rising prevalence of genetic disorders to propel market demand
The rise of genetic disorders is driving increased research into rare and previously undiagnosed neurodevelopmental conditions, supported by advances in genome sequencing and clinical genomics. Recent discoveries, including newly identified mutations in genes such as RPS6KC1, are expanding understanding of complex neurological and developmental diseases. These advancements are strengthening early diagnosis capabilities and accelerating the development of targeted therapies for rare genetic disorders.
The rising prevalence of genetic disorders globally is driving demand for CRISP based gene editing, as it enables precise correction of disease-causing mutations and supports the development of targeted, next-generation genetic therapies. For instance, in 2026, insights from the CDC Gov., genomics, and health overview highlight that genetic disorders arise from changes in DNA ranging from single-gene mutations to chromosomal abnormalities and complex interactions between multiple genes and environmental factors. The CDC reports that rare and genetic conditions include single-gene and chromosomal disorders such as Down syndrome (~1 in 700 births) and diseases like cystic fibrosis affecting ~35,000 people in the U.S. Thus, accelerating CRISPR adoption for precise, personalized, and potentially curative genetic disease therapies.
CRISPR-based Gene Editing Market- Segmentation Analysis:
The Global CRISPR-based Gene Editing Market is segmented on the basis of Product & Service , Application, End Use, and Region.
From a product & service perspective, CRISPR kits & reagents hold a significant share in the CRISPR-based Gene Editing market due to their widespread use in genome editing workflows, high research adoption, and essential role in gene modification. For instance, research by the Department of Pharmaceuticals, Government of India, highlights that the growing demand for kits and reagents is significantly contributing to the expansion of India's medical devices industry. The report states that India's import dependence on IVD reagents increased by nearly 65.4%, reaching around USD 872 million due to rising diagnostic testing demand. Additionally, medical device imports touched approximately USD 8,500 million, growing by 36.8% with expanding healthcare screening and testing infrastructure. Thus, expanding diagnostic and research applications are accelerating global demand for CRISPR kits and reagents.
In terms of application, the biomedical segment represents a key area in the CRISPR-based Gene Editing market, driven by its expanding use in therapeutic development, genetic disorder treatment, oncology research, disease diagnostics, and the growing adoption of ex vivo and in vivo gene editing technologies. For instance, in 2025, research by the OECD org. highlights that Japan is witnessing growing use of biomedical and advanced healthcare technologies. Japan spends around 10.6% of GDP on healthcare, with per capita healthcare expenditure reaching nearly USD 5,790 and universal coverage for 100% of the population. The country also has approximately 184 CT, MRI, and PET scanners per million people and around 203 pharmacists per 100,000 population, reflecting strong adoption of advanced healthcare technologies. The expanding healthcare infrastructure is accelerating biomedical adoption in the CRISPR-based Gene Editing market.
CRISPR-based Gene Editing Market- Geographical Insights
North America holds a key position in the CRISPR-based Gene Editing market, driven by the presence of key biotechnology and pharmaceutical companies and continuous investments in research and development. In April 2025, Danaher Corporation advanced its CRISPR-based gene editing capabilities by strengthening its research and development ecosystem through Integrated DNA Technologies (IDT) and Aldevron, focusing on high-quality DNA, RNA, and CRISPR tool production to accelerate development of next-generation gene editing therapies and improve scalability of personalized treatment solutions. And this strengthens North America's leadership in CRISPR innovation and therapeutic development.
Moreover, Asia-Pacific is expected to grow at a rapid pace in the CRISPR-based Gene Editing market, supported by the expansion of biotechnology and pharmaceutical industries. Countries such as China, Japan, South Korea, and India are making significant investments in genomic research, clinical trials, and CRISPR-based product development, driven by supportive government initiatives and progressive policy reforms. In May 2025, as stated by PIB Gov., at the Bharat Ratna C. Subramaniam Auditorium, NASC Complex, New Delhi, Union Agriculture and Farmers Welfare Minister Shri Shivraj Singh Chouhan launched India's first genome-edited rice varieties, DRR Rice 100 (Kamla) and Pusa DST Rice 1. Developed by ICAR using CRISPR-based genome editing, these varieties offer higher yield, improved climate adaptability, and better water conservation. With this launch, India became the first country to develop genome-edited rice varieties. Therefore, Asia-Pacific is leading CRISPR adoption through strong innovation and policy support.
China plays a key role in the CRISPR-based Gene Editing market, being the first country to conduct human clinical trials using CRISPR-Cas9 for genetic disorders. For instance, the NIH Gov. highlights that China's modern clinical trial system has rapidly expanded from minimal participation in early controlled human studies to a large-scale multicenter randomized clinical research ecosystem. By the structured clinical research phase, China had established hundreds of multicenter RCTs across major therapeutic areas, including oncology, cardiovascular, infectious diseases, and traditional medicine. Modern trials now involve several hundred to over 3,000 participants per Phase II/III study, up from fewer than 100 participants in earlier decades. Thus, China's clinical expansion is accelerating CRISPR gene editing advancements.
CRISPR-based Gene Editing Market- Competitive Landscape:
The CRISPR-based Gene Editing market is highly competitive and moderately consolidated, with several global and specialized biotechnology players driving innovation and commercialization. Leading companies such as CRISPR Therapeutics AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GeneCopoeia, Inc., and Synthego Corporation are strengthening their positions through advanced genome editing platforms, expanding research applications, and continuous product development in gene modification technologies. In May 2025, Danaher used its Business System to deliver the world's first mRNA-based personalized CRISPR therapy in under six months, accelerating treatment for a child with neonatal-onset CPS1 deficiency. Hence, ongoing innovation is accelerating CRISPR therapy development and clinical adoption globally.
Recent Developments:
In May 2025, Bio-Techne Corporation entered into a collaboration with Kytopen to integrate Flowfect(R) continuous flow technology with advanced gene delivery systems, enabling scalable non-viral CRISPR-mediated T-cell engineering and improving efficiency in cell therapy manufacturing workflows.
In April 2025, Synthego Corporation expanded its CRISPR licensing ecosystem through a strategic agreement with Vita Therapeutics to integrate high-fidelity hfCas12Max nuclease technology into next-generation cell therapy programs, enhancing precision and reducing off-target gene editing risks.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CRISPR-BASED GENE EDITING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Revvity, Inc.
- Danaher Corporation
- GenScript Biotech Corporation
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Tocris Bioscience
- OriGene Technologies, Inc.
- Bio-Rad Laboratories
- Bio-Techne Corporation
- New England Biolabs, Inc.
- CRISPR Therapeutics AG
- Agilent Technologies, Inc.
- GeneCopoeia, Inc.
- Synthego Corporation
- System Biosciences LLC
- ToolGen, Inc.
- Rockland Immunochemicals, Inc.
- Horizon Discovery Group
- Abcam, Inc.
- Applied StemCell, Inc.
- Cellecta, Inc.
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2020 - 2033
- Products
- CRISPR Libraries
- CRISPR Kits & Reagents
- Others
- Services
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- By Delivery Method
- Ex Vivo
- In Vivo
- Disease Diagnostics
- Agricultural applications
- Farm Animals Engineering
- Plant Engineering
- Others
- Biomedical
- Therapeutic Development
- By Indication
- Ophthalmology
- Oncology
- Genetic Disorders
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Contract Research Organizations
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. CRISPR-based Gene Editing Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. CRISPR-based Gene Editing Market Snippet by Product & Service
- 2.1.2. CRISPR-based Gene Editing Market Snippet by Application
- 2.1.3. CRISPR-based Gene Editing Market Snippet by End Use
- 2.1.4. CRISPR-based Gene Editing Market Snippet by Country
- 2.1.5. CRISPR-based Gene Editing Market Snippet by Region
- 2.2. Competitive Insights
3. CRISPR-based Gene Editing Key Market Trends
- 3.1. CRISPR-based Gene Editing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. CRISPR-based Gene Editing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. CRISPR-based Gene Editing Market Opportunities
- 3.4. CRISPR-based Gene Editing Market Future Trends
4. CRISPR-based Gene Editing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. CRISPR-based Gene Editing Market : Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. CRISPR-based Gene Editing Market Landscape
- 6.1. CRISPR-based Gene Editing Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. CRISPR-based Gene Editing Market - By Product & Service
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product & Service , 2025 & 2033 (%)
- 7.1.2. Products
- 7.1.2.1. CRISPR Libraries
- 7.1.2.2. CRISPR Kits & Reagents
- 7.1.2.3. Others
- 7.1.3. Services
- 7.1.4. Others
8. CRISPR-based Gene Editing Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. By Delivery Method
- 8.1.2.1. Ex Vivo
- 8.1.2.2. In Vivo
- 8.1.3. Disease Diagnostics
- 8.1.4. Agricultural applications
- 8.1.4.1. Farm Animals Engineering
- 8.1.4.2. Plant Engineering
- 8.1.4.3. Others
- 8.1.5. Biomedical
- 8.1.5.1. Therapeutic Development
- 8.1.5.1.1. By Indication
- 8.1.5.1.2. Ophthalmology
- 8.1.5.1.3. Oncology
- 8.1.5.1.4. Genetic Disorders
- 8.1.5.1.5. Others
9. CRISPR-based Gene Editing Market - By End Use
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
- 9.1.2. Contract Research Organizations
- 9.1.3. Academic & Research Institutes
- 9.1.4. Pharmaceutical & Biotechnology Companies
- 9.1.5. Others
10. CRISPR-based Gene Editing Market - By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. CRISPR-based Gene Editing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. CRISPR-based Gene Editing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.8. UK
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.8.3. UK Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.8.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.9. France
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.9.3. France Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.9.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.10.3. Italy Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.10.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
- 10.3.11.1. Overview
- 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.11.3. Spain Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.11.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
- 10.3.12.1. Overview
- 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.12.3. The Netherlands Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Overview
- 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
- 10.3.14.1. Overview
- 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.14.3. Russia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.14.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.15.3. Poland Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.15.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
- 10.3.16.1. Overview
- 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.16.3. Denmark Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.16.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
- 10.3.17.1. Overview
- 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. CRISPR-based Gene Editing Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.7. China
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.7.3. China Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.7.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.8. India
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.8.3. India Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.8.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.12.3. Indonesia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.13.3. Thailand Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.15.3. Taiwan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.15.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
- 10.4.16.1. Overview
- 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.16.3. Vietnam Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.16.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
- 10.4.17.1. Overview
- 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.17.3. Rest of APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.17.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. CRISPR-based Gene Editing Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. CRISPR-based Gene Editing Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.8.3. UAE Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.8.5. UAE Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.13.3. Iran Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.13.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
- 10.6.14.1. Overview
- 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.14.3. Qatar Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.14.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
- 10.6.15.1. Overview
- 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.15.3. Rest of MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.15.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- CRISPR-based Gene Editing Industry
- 11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
- 11.2. Company Profiles
- 11.2.1. Revvity, Inc.
- 11.2.2. Danaher Corporation
- 11.2.3. GenScript Biotech Corporation
- 11.2.4. Merck KGaA
- 11.2.5. Thermo Fisher Scientific, Inc.
- 11.2.6. Tocris Bioscience
- 11.2.7. OriGene Technologies, Inc.
- 11.2.8. Bio-Rad Laboratories
- 11.2.9. Bio-Techne Corporation
- 11.2.10. New England Biolabs, Inc.
- 11.2.11. CRISPR Therapeutics AG
- 11.2.12. Agilent Technologies, Inc.
- 11.2.13. GeneCopoeia, Inc.
- 11.2.14. Synthego Corporation
- 11.2.15. System Biosciences LLC
- 11.2.16. ToolGen, Inc.
- 11.2.17. Rockland Immunochemicals, Inc.
- 11.2.18. Horizon Discovery Group
- 11.2.19. Abcam, Inc.
- 11.2.20. Applied StemCell, Inc.
- 11.2.21. Cellecta, Inc.
- 11.2.22. Others
12. 360 Degree AnalystView
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
